Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (437)	12/19/2000 10:32:07 PM
From: BulbaMan	Read Replies (1) \| Respond to of 1833

More BMY sales of Cadus filed with SEC. It's hard to believe BMY is selling its 2 million share block of Cadus in dribs and drabs. Are these guys just plain stupid or maybe someone at BMY owes the KDUS market-maker a favor? Any other ideas to explain such nonsensical selling by BMY? Anyway here's the Form 4 details. The following transactions were listed on a Form 4 document filed with the SEC. Name: BRISTOL MYERS SQUIBB CO Title: Beneficial Owner of more than 10% of a Class of Security Remaining Shares: 1.896 Mil Trade Date Transaction Quantity Price Value 11/30/00 Sold 10,000 $1.00 $10,000 11/21/00 Sold 1,000 $1.03 $1,030 11/20/00 Sold 6,000 $1.04 $6,218 11/17/00 Sold 5,000 $1.05 $5,250 11/14/00 Sold 10,000 $1.02 $10,156